Gefitinib CAS 184475-35-2

Khoom Qhia:

Khoom npe: Gefitinib CAS TSIS: 184475-35-2

Txhais:

Xob;

N- (3-Chloro-4-fluorophenyl) -7-methoxy-6- (3-morpholinopropoxy) quinazolin-4-amine;

Irressat;

Tshuaj& Cov Khoom Uas Lub Cev:

Tswm Cim: Lub teeb daj crystalline cov hmoov

Ntsuas: ≥98.0%

Qhov ceev: 1.322g / cm3

Lub Ntsiab Kub: 586.8 ℃ ntawm 760 mmHg

Melting Point: 119-120 ℃

Flash Point: 308.7 ℃

Nqe Taw Qhia Tshwj Xeeb: 1.621

Vapor Siab: 0mmHg ntawm 25 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

Lub Cim: GHS07

Kos Npe: Lo Lus Ceeb Toom

Cov Lus Qhia Kev Nyab Xeeb: S24 / 25; S36; S26

HS Code: 29143900

WGK Lub Teb Chaws Yelemees: 3

RTECS: HP1149700

Cov Lus Ceeb Toom Yuav Muaj: R36 / 37/38

Txoj Cai Kev Nyab Xeeb: Xi

Cov ntawv ceeb toom: P301 + P312 + P330; P305 + P351 + P338

Cov Lus Tshaj Tawm: H302; Qauv H315; H319; H335

Gefitinib (ZD1839) (INN,, lub npe lag luam Iressa, ua lag luam los ntawm AstraZeneca thiab Teva), yog cov tshuaj uas siv rau qee yam mis, ntsws thiab lwm yam mob qog nqaij hlav. Gefitinib yog EGFR inhibitor, zoo ib yam li erlotinib, uas cuam tshuam kev taw qhia los ntawm tus kabmob epidermal growth factor receptor (EGFR) hauv cov phiaj hlwb. Yog li, nws tsuas yog ua tau zoo hauv kev mob qog nqaij hlav nrog mutated thiab overactive EGFR. Txawm li cas los xij, meta-kev tsom xam tsis tau pom tias muaj kev txhim kho hauv kev muaj sia nyob tag nrho, uas yog, nws tsis txuas ntxiv lub neej.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.

Cim npe nrov: gefitinib cas 184475-35-2, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

• Tug: 5-chloro-4-hydroxy-1H-pyridin-2-ib CAS 103766-25-2
• Tom ntej: Erlotinib CAS 183321-74-6